This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3she
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==Novel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series== | ==Novel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series== | ||
<StructureSection load='3she' size='340' side='right' caption='[[3she]], [[Resolution|resolution]] 2.25Å' scene=''> | <StructureSection load='3she' size='340' side='right' caption='[[3she]], [[Resolution|resolution]] 2.25Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[3she]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3she]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3SHE OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3SHE FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=I85:N-{4-[(3S)-4-OXO-1,4,5,6-TETRAHYDROSPIRO[PIPERIDINE-3,7-PYRROLO[3,2-C]PYRIDIN]-2-YL]PYRIDIN-2-YL}-3-(TRIFLUOROMETHYL)BENZAMIDE'>I85</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=I85:N-{4-[(3S)-4-OXO-1,4,5,6-TETRAHYDROSPIRO[PIPERIDINE-3,7-PYRROLO[3,2-C]PYRIDIN]-2-YL]PYRIDIN-2-YL}-3-(TRIFLUOROMETHYL)BENZAMIDE'>I85</scene></td></tr> | ||
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">MAPKAPK3 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">MAPKAPK3 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span></td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3she FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3she OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3she RCSB], [http://www.ebi.ac.uk/pdbsum/3she PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3she FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3she OCA], [http://pdbe.org/3she PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3she RCSB], [http://www.ebi.ac.uk/pdbsum/3she PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3she ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| Line 18: | Line 19: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 3she" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Human]] |
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
[[Category: Kazemier, B]] | [[Category: Kazemier, B]] | ||
Revision as of 11:15, 5 August 2016
Novel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series
| |||||||||||
